Efficacy and Safety of TwHF and MTX in Patients With Rheumatoid Arthritis
Status:
Unknown status
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
Rheumatoid Arthritis (RA) is an autoimmune disease that results in a chronic inflammatory
disorder that may affect many synovial joints, and may cause serious disability. It has been
confirmed that Tripterygium Wilfordii has effects of anti-inflammatory, immunosuppressive and
cartilage protection. This is a multicenter ,double Blind, randomized study to evaluated the
efficacy and safety of Tripterygium Wilfordii in treating of patients with rheumatoid
arthritis (RA) and establish a prediction model for Tripterygium Wilfordii response of
rheumatoid arthritis (RA).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences